Vietnam Drug Makers Hurt By Ban On Retail Price Increases
This article was originally published in PharmAsia News
Executive Summary
Vietnam's drug-making industry is feeling the pain of the government's ban on price increases at the retail level. Drug manufacturers as well as importers, said an industry member at a Drug Administration of Vietnam conference, are being hit by high inflation and an ever-changing exchange rate at the same time. Many drug makers, he said, are forced to use the black market to get the foreign currency they need to buy drugs from abroad. Another noted the price of raw materials needed by local drug makers cost as much as six times more than a year ago. (Click here for more